Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Helgeland

Showing results (31-40 of 68) with videos related to

Pageof 7
Sort By:
AJNR. American Journal of Neuroradiology|August 18, 2012
Simulating CSF flow dynamics in the normal and the Chiari I subarachnoid space during rest and exertionS O Linge, K A Mardal, V Haughton, et al.
Acta Pharmacologica Et Toxicologica|January 1, 1984
Changes in the lipoprotein profile during antihypertensive therapyA Helgeland, P Leren, S Kjeldsen, et al.
Clinical Science (London, England : 1979)|December 1, 1981
Increased peripheral release of noradrenaline and uptake of adrenaline in essential hypertension?S E Kjeldsen, B Flaaten, I Eide, et al.
American Journal of Epidemiology|April 1, 1988
Correlates of blood pressure change in middle-aged male mild hypertensives: results from the untreated control group in the Oslo hypertension trial. The Oslo StudyI Holme, A Helgeland, I Hjermann, et al.
Acta Medica Scandinavica|January 1, 1976
The intercorrelation of serum cholesterol, cigarette smoking and body weight. The Oslo StudyI Hjermann, A Helgeland, I Holme, et al.
Acta Medica Scandinavica. Supplementum|January 1, 1983
Increased peripheral catecholamine release in patients with long-standing, untreated essential hypertensionS E Kjeldsen, B Flaaten, I Eide, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|May 1, 1982
Evidence of increased peripheral catecholamine release in patients with long-standing, untreated essential hypertensionS E Kjeldsen, B Flaaten, I Eide, et al.
Acta Medica Scandinavica. Supplementum|January 1, 1979
HDL-cholesterol in antihypertensive treatment. The Oslo StudyA Helgeland, P Leren, S C Enger, et al.
American Journal of Epidemiology|July 1, 1980
Four and two-thirds years incidence of coronary heart disease in middle-aged men: the Oslo studyI Holme, A Helgeland, I Hjermann, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|August 10, 1980
[The Oslo study. 4-year mortality, coronary risk factors and socioeonomic indicators]I Holme, A Helgeland, I Hjermann, et al.
Pageof 7

Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
AJNR. American Journal of Neuroradiology|August 18, 2012
Simulating CSF flow dynamics in the normal and the Chiari I subarachnoid space during rest and exertionS O Linge, K A Mardal, V Haughton, et al.
Acta Pharmacologica Et Toxicologica|January 1, 1984
Changes in the lipoprotein profile during antihypertensive therapyA Helgeland, P Leren, S Kjeldsen, et al.
Clinical Science (London, England : 1979)|December 1, 1981
Increased peripheral release of noradrenaline and uptake of adrenaline in essential hypertension?S E Kjeldsen, B Flaaten, I Eide, et al.
American Journal of Epidemiology|April 1, 1988
Correlates of blood pressure change in middle-aged male mild hypertensives: results from the untreated control group in the Oslo hypertension trial. The Oslo StudyI Holme, A Helgeland, I Hjermann, et al.
Acta Medica Scandinavica|January 1, 1976
The intercorrelation of serum cholesterol, cigarette smoking and body weight. The Oslo StudyI Hjermann, A Helgeland, I Holme, et al.
Acta Medica Scandinavica. Supplementum|January 1, 1983
Increased peripheral catecholamine release in patients with long-standing, untreated essential hypertensionS E Kjeldsen, B Flaaten, I Eide, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|May 1, 1982
Evidence of increased peripheral catecholamine release in patients with long-standing, untreated essential hypertensionS E Kjeldsen, B Flaaten, I Eide, et al.
Acta Medica Scandinavica. Supplementum|January 1, 1979
HDL-cholesterol in antihypertensive treatment. The Oslo StudyA Helgeland, P Leren, S C Enger, et al.
American Journal of Epidemiology|July 1, 1980
Four and two-thirds years incidence of coronary heart disease in middle-aged men: the Oslo studyI Holme, A Helgeland, I Hjermann, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|August 10, 1980
[The Oslo study. 4-year mortality, coronary risk factors and socioeonomic indicators]I Holme, A Helgeland, I Hjermann, et al.
Pageof 7